Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00261664 · ClinicalTrials.gov registry record · Phase 1
Empowering Elders Through Technology
A Phase 1 study of Congestive Heart Failure, sponsored by Robert Wood Johnson Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 290
- Enrollment target
- 1
- Study location
NCT00261664: Completed Phase 1 study of Congestive Heart Failure, sponsored by Robert Wood Johnson Foundation.
NCT00261664 is a Phase 1 study of Congestive Heart Failure that has completed, run by Robert Wood Johnson Foundation. The registered enrollment target is 290 participants, below the 324-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00261664, a Phase 1 study of Congestive Heart Failure, has completed, sponsored by Robert Wood Johnson Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 290 participants
- Enrollment target
- 1
- Study location
Study Summary
Telehomecare is a technology that individuals use in their homes to communicate with health providers electronically. This technology can help them function at a higher level and avoid undesirable hospitalizations by making changes in their everyday behaviors, but research is needed to understand how telehomecare supports health behavior change and leads to improved health status. The hypothesis being tested is that the use of an electronic method of monitoring and transmitting health information facilitates patient empowerment, with subsequent effects on the patient's ability to manage her/his treatment regimen more effectively. The study will explore the relationship between telehomecare and acquisition of knowledge, and will show whether changes in knowledge levels translate to changes in behaviors and improved health outcomes. The effects of two different telehomecare systems (nurse-directed vs. patient-directed) on knowledge, self-management, and health status will be compared. A further goal is to illuminate the attitudes of physicians regarding the use of telehomecare in the treatment of their elderly, community dwelling patients. Results will inform managers and policymakers who are responsible for integrating eHealth mechanisms into chronic disease protocols, funding health care programs, and creating policies that support the use of information technology by all Americans.
Conditions Studied
Interventions
- DEVICE telehomecare
Study Locations (1)
Pennsylvania
- Pennsylvania State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2003-09 |
| Est. Completion | 2005-07 |
| Phase | Phase 1 |
What the finished NCT00261664 record still lists
NCT00261664 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 324-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (10% lower).
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which telehomecare is the first listed.
NCT00261664 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00261664 about?
NCT00261664 is a clinical study titled "Empowering Elders Through Technology". Telehomecare is a technology that individuals use in their homes to communicate with health providers electronically. This technology can help them function at a higher level and avoid undesirable hospitalizations by making changes in their everyday behaviors, but research is needed to understand ho...
What is the current status of trial NCT00261664?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 290 participants. The study started on 2003-09. Estimated completion is 2005-07.
What conditions does trial NCT00261664 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT00261664?
The interventions under investigation include: telehomecare (DEVICE).
Who is sponsoring clinical trial NCT00261664?
This trial is sponsored by Robert Wood Johnson Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00261664 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00261664's enrollment target sits among peer trials
290 17th of 51 higher than 35 of 51 other Congestive Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
RECRUITING · Phase 1
-
AB-1002 in Patients With Class III Heart Failure
ACTIVE NOT RECRUITING · Phase 1
-
Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO)
COMPLETED · Phase 1
-
Palliative Care for People With HF
RECRUITING
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
-
Stress and Congestive Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia